相关实验视频

Updated: Jun 7, 2025

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

新的基于quinazolinone的免疫调节性抗癌thalidomide类似物:设计,合成和生物评估

Maged Mohammed Saleh Al Ward¹, Abdallah E Abdallah¹, Mohamed F Zayed^1,2

¹Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, 11884, Egypt.

Future medicinal chemistry

|November 12, 2024

概括

新的quinazolinone衍生物,7d和12显示出有前途的免疫调节和抗癌活性,可能作为改进的thalidomide类似物. 这些化合物有效地减少了关键的炎症标志物,并增强了细胞死亡途径.

科学领域:

药用化学医学化学
免疫学免疫学免疫学
在瘤学瘤学.

背景情况:

thalidomide类似物对于治疗各种疾病至关重要.
之前的研究重点是开发新的thalidomide衍生物.

研究的目的:

为了设计,合成和评估新的基纳佐林基分子与谷胺基.
与thalidomide相比,评估这些新型化合物的免疫调节和抗癌潜力.

主要方法:

合成基于quinazolinone的分子,其中包含一个glutarimide部分.
免疫调节和抗癌活动的生物评估.
定量瘤坏死因子-α (TNF-α),核因子-kappa B (NF-κB) P65,血管内皮生长因子 (VEGF) 和caspase-8的水平.

主要成果:

化合物7d和12显示出显著的免疫调节作用,在降低TNF-α,NF-κB P65和VEGF水平方面表现优于thalidomide.
这两种化合物显著增加了酶-8水平,表明诱导亡的增强.
与thalidomide相比,化合物12表现出优越的免疫调节特性.

结论:

化合物7d和12具有显著的生物活性,需要进一步研究.
这些新型衍生品显示出开发成临床有用的thalidomide类似物的潜力.
进一步的修改可能会优化它们的治疗效果.

关键词:

这是一种抗癌药物.葡萄糖胺的使用方法免疫调节免疫调节免疫调节这是一种quinazolinone.泰利多胺的使用方法

更多相关视频

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates

Published on: March 6, 2019

相关概念视频

Drugs that Destabilize Microtubules

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: 5-HT₃ Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...